Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - Any
Updated:11/30/2013
Start Date:August 2012
End Date:July 2013

Use our guide to learn which trials are right for you!


Optimizing patient survival and organ utility is a constant struggle for the liver
transplant community. Despite rigorous cardiovascular evaluation before liver
transplantation cardiovascular events are one of the leading causes of post-transplant
morbidity and mortality in both early and late post transplant periods. Poor performance on
measures of cardiopulmonary fitness has been associated with worse outcomes in liver
transplant candidates. The investigators seek to determine the feasibility of obtaining
measures of cardiopulmonary performance in liver transplant candidates from standard
cardiopulmonary exercise testing (CPET) and from a modified 3 minute step test and to
determine whether the 3 minute step test is suitable for the assessment of cardiopulmonary
fitness in a future outcome study.


Subjects: 10 patients ≥40 years of age with cirrhotic end-stage liver disease undergoing
liver transplantation evaluation at Mayo Clinic, Rochester, MN. Patients who require
multi-organ transplant, or who have non-cirrhotic liver disease (neuroendocrine,
amyloidosis, etc.) will be excluded. Each subject will undergo both standard CPET and
modified 3 minute step test.

Exercise testing. Subjects will perform both tests during one visit to the cardiopulmonary
research lab. A 30-60 minute period between tests will given. 5 patients will perform
submaximal stress testing first and 5 will perform the full CPET first.

CPET: Patients will perform a 6 minute cardiopulmonary exercise test using the recumbent
stationary bicycle facilitated by the co-investigators at the St Mary's cardiopulmonary
exercise laboratory. Standard 12-lead electrocardiograms will be obtained at rest, each
minute during exercise, and for at least five minutes during the recovery phase; blood
pressure will be measured using a standard cuff sphygmomanometer. Minute ventilation (VE),
breathing frequency (fR), tidal volume (VT), oxygen consumption (VO2), CO2 production
(VCO2), RER, and end-tidal CO2 (PETCO2) will be obtained breath-by-breath and averaged over
a 30-second period at rest and the last 30 seconds of each minute during exercise. In
addition, heart rate (HR) and oxygen saturation (SaO2) will be obtained continuously using
pulse oximetry. From these data, derived variables such as the VE/VCO2 ratio, oxygen pulse
(VO2/HR) and an index of pulmonary capacitance (O2 pulse /[1/PETCO2]) are calculated at
rest and during exercise. Ventilatory efficiency slopes (VE/VCO2 slope) [VE liter/min _ m
(VCO2, liter/min) _ b], where m _ VE/VCO2 slope, and oxygen uptake efficiency slopes (OUES)
[VO2, liter/min _ m (log10VE) _ b], where m _ OUES, are calculated using all exercise data
points via least squares linear regression.

Modified 3 minute step test: Each participant will perform a sub-maximal exercise test that
consists of 2 minutes of resting baseline, 3 minutes of step exercise, and 1 minute of
recovery. Breathing pattern, gas exchange (as described above), and heart rate will be
monitored using a simplified gas analysis system (SHAPE Medical Systems, Inc, St. Paul, MN).
Submaximal testing will be defined by respiratory exchange ratio (RER), and perceived
exertion (RPE). An exercise RER of 0.9 and RPE of 12 to 13 on the Borg scale (range, 6 to
20) is considered to be a sub-maximal level. At the end of the first & second minute of step
exercise, RER and RPE will be recorded and the step rate adjusted (a patient with a low RER
(< 0.8) and RPE (< 8) would increase the step rate for the second minute, whereas a patient
with a higher RER (> 0.85) and RPE (> 11) would maintain the same step rate). On completion
of the 3-minute step exercise, recovery data will be collected for 1 minute.

Inclusion Criteria:

- listed for liver transplantation with end stage liver disease

Exclusion Criteria:

- patients listed for liver transplant without end stage liver disease
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials